RCS - Tristel PLC - Tristel welcomes Cardiff University wipes study <Origin Href="QuoteRef">TSTL.L</Origin>

TristelAnnouncement

16/07/2015 10:10

RNS Number : 6657P
Tristel PLC
09 June 2015
Tristel plc
("Tristel" or the "Company")
Tristel welcomes Cardiff University study on detergent wipes
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, welcomes the recent study by Cardiff University published in American Journal of Infection Control which concludes that commercially available detergent wipes are inconsistent in their ability to remove spores of bacteria from hospital surfaces following a 10 second wipe.
Tristel's range of infection prevention products for hospitals have been developed specifically to disinfect medical instruments, using a proprietary chlorine dioxide chemistry clinically proven to be effective against the most common bacteria, micro-bacteria, viruses and fungi as well as being effective at a sporicidal level. This chemistry has been applied to Tristel's range of surfaces products so that the same effectiveness can be achieved on hospital surfaces, the area that this study shows to be ineffectively cleaned when only detergent wipes are used.
Commenting Paul Swinney, Chief Executive Officer of Tristel, said:
"There is a huge difference between our proven disinfectant chemistry, which is commonly used in the majority of UK hospitals to clean key medical instruments, and the simple detergent wipes that have been shown by this study to be inconsistent in killing superbugs such as MRSA or C. difficile. 
"The study highlights the very issue that we deal with every day in our engagement with hospitals around the world, which is the need to step up surface cleaning from regular detergents to a more powerful disinfectant that is effective against tackling some of the deadliest hospital acquired infections.
"I have no doubt that the wider understanding of this issue provides Tristel with a huge opportunity to press our case for the use of our products on hospital surfaces where the common practice is shown to be ineffective. In short, hospitals can no longer just use everyday detergents to combat infections, they need to use effective disinfectants like ours."
For further information please contact:
Tristel plc
www.tristel.com
Paul Swinney, Chief Executive Officer
Tel: 01638 721 500
Liz Dixon, Finance Director
Walbrook PR Ltd
Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus
Mob: 07980 541 893 
Lianne Cawthorne
Mob: 07854 391 303
finnCap
Tel: 020 7600 1658
Geoff Nash (Corporate Finance)
Giles Rolls (Corporate Finance)
Stephen Norcross (Corporate Broking)

This information is provided by RNS
The company news service from the London Stock Exchange
  END
NRAUGUWCQUPAGPB